To understand the role of POU2F2 in GBM, we first demonstrated that POU2F2 expression levels correlate with GBM by performing immunohistochemical staining (IHC) using primary tissue microarray samples from GBM patients. This evidence concerns the gene POU2F2 and glioblastoma.